1226606

Frontida BioPharm Inc — FEI 2523348

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 7, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Philadelphia, PA (United States)